Skip to Main Content Presents: Improving Quality Metrics and Reducing Cost of Care with Access to Real-Time Continuous Glucose Monitoring

July 9, 2021
Coverage and Benefit Design
Economic Outcomes
CE Activities

Release Date: July 9, 2021
Expiration Date: January 31, 2023

CE Now Expired

Target Audience

This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, registered nurses, and other managed health care professionals.

Credit Available

Up to 1.0 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)

Educational Objectives

  • Characterize the value of health technology and remote patient monitoring as part of a comprehensive management strategy for diabetes to improve glycemic outcomes
  • Discuss the positive impact of pharmacy coverage on payer management interventions, provider administrative burden, member experience and access, and overall cost of care
  • Review the potential of rtCGM to improve diabetes performance measures via hypoglycemia risk reduction, improved HbA1c, and reduced resource utilization with case scenarios (e.g., pregnancy; senior populations)

Expert Faculty

Jeffrey Dunn, PharmD, MBA
Head of Clinical Pharmacy
Berkshire Hathaway/Geico (formerly Haven,
the Amazon, Berkshire Hathaway, JPMorgan Chase healthcare venture)
Formerly VP, Clinical Strategy and Programs and Industry Relations Magellan Rx Management

Maria Lopes, MD, MS
Former Chief Medical Officer
Magellan Health

Janet B. McGill, MD, MA, FACE, FACP
Professor of Medicine
Washington University School of Medicine

Vanita Pindolia, PharmD, BCPS, MBA
Formerly Vice President, Ambulatory Clinical Pharmacy Programs_PCM
Henry Ford Health System/Health Alliance Plan of Michigan

Jointly provided by Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Dexcom, Inc.